Market Research Report
Global Urinary Incontinence Devices Market (2018 - 2024)
|Global Urinary Incontinence Devices Market (2018 - 2024)|
Published: December 20, 2018
Content info: 295 Pages
Delivery time: 1-2 business days
The Global Urinary Incontinence Devices Market size is expected to reach $1.87 billion by 2024, rising at a market growth of 11.2% CAGR during the forecast period. Urinary incontinence is an unintentional leakage of urine, and it is differentiated into four types, namely, stress urinary incontinence, urge urinary incontinence, overflow urinary incontinence, and functional urinary incontinence. Urinary incontinence is most commonly found in women. Development of innovative urinary catheters, growing preference for surgical treatment for urinary incontinence is the factors that drive the growth of the market during the forecast period. In addition, rise in geriatric population that normally suffers from urinary incontinence or incontinence associated with chronic conditions (kidney stones, miscarriages, paralysis, and neuromuscular injury) would be a factor that would drive the market growth.
Based on product, the market report segments the market into Vaginal Slings, Urinary Catheters, Electrical Stimulation Devices, Artificial Urinary Sphincters, and Other Devices. The category segment includes External Urinary Incontinence Devices and Internal Urinary Incontinence Devices. The Incontinence Type segment covers Stress Incontinence, Urge Incontinence, Overflow Incontinence, and Functional Incontinence. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include C. R. Bard, Inc., Boston Scientific Corporation, Coloplast Group, Medtronic plc, Ethicon US, LLC. (Johnson & Johnson), B. Braun Melsungen AG, Teleflex Incorporated, Atlantic Therapeutics, and Zephyr Surgical Implants